139 related articles for article (PubMed ID: 8589296)
1. Treatment of aluminum overload using a cartridge with immobilized desferrioxamine.
Anthone S; Ambrus CM; Kohli R; Min I; Anthone R; Stadler A; Stadler I; Vladutiu A
J Am Soc Nephrol; 1995 Oct; 6(4):1271-7. PubMed ID: 8589296
[TBL] [Abstract][Full Text] [Related]
2. Rapid removal of DFO-chelated aluminum during hemodialysis using polysulfone dialyzers.
Molitoris BA; Alfrey AC; Alfrey PS; Miller NL
Kidney Int; 1988 Jul; 34(1):98-101. PubMed ID: 3172641
[TBL] [Abstract][Full Text] [Related]
3. Desferrioxamine in the treatment of aluminum overload.
Ackrill P; Day JP
Clin Nephrol; 1985; 24 Suppl 1():S94-7. PubMed ID: 3842106
[TBL] [Abstract][Full Text] [Related]
4. Deferoxamine and coated charcoal hemoperfusion to remove aluminum in dialysis patients.
McCarthy JT; Milliner DS; Schmidt DF; Schniepp BJ; Kurtz SB; Johnson WJ
Kidney Int; 1988 Dec; 34(6):804-8. PubMed ID: 3210542
[TBL] [Abstract][Full Text] [Related]
5. Low-dose (5 mg/kg) desferrioxamine treatment in acutely aluminium-intoxicated haemodialysis patients using two drug administration schedules.
Barata JD; D'Haese PC; Pires C; Lamberts LV; Simões J; De Broe ME
Nephrol Dial Transplant; 1996 Jan; 11(1):125-32. PubMed ID: 8649620
[TBL] [Abstract][Full Text] [Related]
6. [The causes, diagnosis and treatment of aluminum toxicity in patients with chronic renal failure undergoing dialysis].
Wang G; Zhu P; Wang S
Zhonghua Nei Ke Za Zhi; 1996 Jan; 35(1):36-40. PubMed ID: 9275645
[TBL] [Abstract][Full Text] [Related]
7. Immobilized desferrioxamine (DFO) for the extracorporeal removal of aluminum.
Anthone S; Ambrus CM; Horvath C; Kalghatgi K
ASAIO Trans; 1987; 33(3):744-8. PubMed ID: 3676012
[No Abstract] [Full Text] [Related]
8. [Aluminum poisoning in dialysis patients--diagnosis and therapy].
Vogelsang U
Schweiz Rundsch Med Prax; 1994 Jun; 83(24):738-56. PubMed ID: 8023059
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with desferrioxamine in dialysis patients with aluminium toxicity.
McCarthy JT; Milliner DS; Johnson WJ
Q J Med; 1990 Mar; 74(275):257-76. PubMed ID: 2117295
[TBL] [Abstract][Full Text] [Related]
10. Accelerated removal of deferoxamine mesylate-chelated aluminum by charcoal hemoperfusion in hemodialysis patients.
Delmez J; Weerts C; Lewis-Finch J; Windus D; Slatopolsky E
Am J Kidney Dis; 1989 Apr; 13(4):308-11. PubMed ID: 2705449
[TBL] [Abstract][Full Text] [Related]
11. Improvement of anaemia with desferrioxamine in haemodialysis patients.
Praga M; Andrés A; de la Serna J; Ruilope LM; Nieto J; Estenoz J; Millet VG; Arnaiz F; Rodicio JL
Nephrol Dial Transplant; 1987; 2(4):243-7. PubMed ID: 3118265
[TBL] [Abstract][Full Text] [Related]
12. [Severe ocular toxicity of desferrioxamine in the hemodialyzed patient].
Bournerias F; Monnier N; Dufier JL; Réveillaud RJ
Nephrologie; 1987; 8(1):27-9. PubMed ID: 3587485
[TBL] [Abstract][Full Text] [Related]
13. Comparison of low-dose deferoxamine versus standard-dose deferoxamine for treatment of aluminium overload among haemodialysis patients.
Kan WC; Chien CC; Wu CC; Su SB; Hwang JC; Wang HY
Nephrol Dial Transplant; 2010 May; 25(5):1604-8. PubMed ID: 19948879
[TBL] [Abstract][Full Text] [Related]
14. Haemofiltration or haemodialysis in aluminium elimination?
Sulkova S; Laurincova Z; Válek A
Nephrol Dial Transplant; 1991; 6 Suppl 3():3-5. PubMed ID: 1775263
[TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of aluminum toxicity including chelation therapy: status and research needs.
Yokel RA; Ackrill P; Burgess E; Day JP; Domingo JL; Flaten TP; Savory J
J Toxicol Environ Health; 1996 Aug; 48(6):667-83. PubMed ID: 8772805
[TBL] [Abstract][Full Text] [Related]
16. Thrombocytopenia associated with intravenous desferrioxamine.
Walker JA; Sherman RA; Eisinger RP
Am J Kidney Dis; 1985 Oct; 6(4):254-6. PubMed ID: 4050784
[TBL] [Abstract][Full Text] [Related]
17. Effect of desferrioxamine infusion on red blood cell aluminum.
Umeda M; Umimoto K; Tsurusaki K; Izumi N; Kishimoto T; Maekawa M
ASAIO Trans; 1988; 34(3):297-9. PubMed ID: 3196524
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of low-dose desferrioxamine for the estimation of aluminium overload in haemodialysis patients.
Janssen MJ; van Boven WP
Pharm World Sci; 1996 Oct; 18(5):187-91. PubMed ID: 8933580
[TBL] [Abstract][Full Text] [Related]
19. The 3-hydroxypyridin-4-ones more effectively chelate aluminum in a rabbit model of aluminum intoxication than does desferrioxamine.
Yokel RA; Meurer KA; Skinner TL; Fredenburg AM
Drug Metab Dispos; 1996 Jan; 24(1):105-11. PubMed ID: 8825197
[TBL] [Abstract][Full Text] [Related]
20. Estimation of statistical moments for desferrioxamine and its iron and aluminum chelates: contribution to optimisation of therapy in uremic patients.
Andriani M; Nordio M; Saporiti E
Nephron; 1996; 72(2):218-24. PubMed ID: 8684530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
